In my previous post, I mentioned pharmacovigilance while discussing ADRs. But what exactly is pharmacovigilance?
Pharmacovigilance is the science of detecting, assessing, monitoring, and preventing adverse drug reactions (ADRs) and other drug-related problems. In simple terms, it focuses on drug safety.
Many people think that once a drug is approved after clinical trials, its safety is fully guaranteed. But in reality, rare or long-term side effects may only appear when the drug is used by a larger population.
This is why pharmacovigilance is important. It ensures that medicines remain safe even after they enter the market. Drug safety is not a one-time process — it continues throughout the life cycle of a medicine.
In the next post (Part 2), we’ll look at how pharmacovigilance actually works and at which stages of clinical trials and post-marketing it is performed.
“Spot on! Keeping drugs safe isn’t just a one-time thing; it happens for as long as the medicine is on the market. Thanks for sharing why this part of the industry is so important.”
Pharmacovigilance reminds us that drug safety doesn’t end at approval — it evolves with real-world use. Continuous monitoring is what truly keeps patients protected.
